Pay in 4 interest-free payments of $5.72 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
DecramerMRutten-van MlkenMDekhuijzenPNTroostersTvan HerwaardenCPellegrinoRet alEffects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (bronchitis randomized on NAC cost-utility study, BRONCUS): a randomised placebo-controlled trial
Despite substantial progress in therapeutic interventions, recurrence rates persist at elevated levels, Individuals presenting with relapsed or refractory B-ALL exhibit significantly reduced rates of remission, with an overall five-year survival probability of merely 20% 2,3
Next, in parallel to the upper experiments (Fig
However, for long-term and high-dose use, it is important to seek medical advice based on individual needs
US$ 24.13
US$ 21.23
US$ 22.17
US$ 20.01
US$ 25.00
US$ 29.27
